Optimization of a microfluidic device for single bacterial cell genomics
Optimization of a microfluidic device for single bacterial cell genomics
批准号:
7571520
负责人:
DAVID A. RELMAN
金额:
$55.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2011-07-31
关键词:
AutomationBiologyCell CountCell SeparationCellsCommunitiesDNADNA Sequence AnalysisDataDevelopmentDevicesDiagnosisDiseaseEnvironmental PollutionFluorescent in Situ HybridizationGene ExpressionGenomeGenomicsGoalsHealthHumanHuman MicrobiomeHuman bodyIndigenousIndividualLasersLeadLifeMeasuresMicrofluidic MicrochipsMicrofluidicsNoiseNumbersOpticsOral cavityPolymerase Chain ReactionProtocols documentationPublic HealthRNAReagentResearchReverse TranscriptionSamplingScienceSignal TransductionSpeedSurveysTechniquesTechnologyTestingTranscriptUnited States National Institutes of HealthWorkcell typedesigndigitalfluorescence imaginggenome sequencingimprovedmembermicrobialmicrobial communitymicroorganismnanolitrenew technologynovel
中文摘要
描述(由申请人提供):探索人类微生物组的特征是一个艰巨的目标,但它有望显著提高我们对健康的理解和对各种疾病状态的管理。在这一探索中,人类微生物群的两个特征特别提出了重大挑战:尚未培育的物种的比例和数量巨大,以及微生物群落的极端不均匀性,导致大量潜在重要的群落成员未能在常规调查中“看到”。鉴定、分离和测序单个细菌细胞基因组的能力将使我们能够表征和了解稀有和未培养的微生物物种,并极大地促进我们对人类微生物组的理解。在最近的工作中,设计和制造了一种微流体装置,具有模拟集成电路的特征;该装置分离单个细菌细胞,并允许以纳升体积扩增其基因组。在本申请中,提出了对该微流体装置进行优化和增强的计划,以减少环境污染,更容易捕获稀有细胞类型,更快地筛选大量细胞,更容易从单个细胞中测量基因表达。这项工作的长期目标是提高我们对人类微生物群落的理解,特别是对新的或特征不明显的、未培养的微生物群落成员的理解。该提案回应了美国国立卫生研究院人类微生物组计划提出的关键未满足的需求。本建议的具体目标如下:目标1。减少环境DNA对单细胞基因组序列数据的贡献,提高细胞分选、基因组扩增微流控装置获得的序列数据的“信噪比”。实验方法包括将光学(激光)镊子集成到设备中。目标2。目的:提高微流体装置对稀有微生物群落成员的检测和捕获能力。实验方法包括荧光原位杂交技术、特异性探针和荧光成像与微流体装置的集成。目标3。利用微流体装置提高单细胞筛选和分离的速度。实验方法涉及更多高度并行的微器件设计,激光功率和激光光路的优化,以及细胞操作的进一步自动化。目标4。提高对单个细菌细胞的基因表达分析能力。实验方法包括开发芯片上的RNA分离、逆转录和使用数字PCR来量化单细胞的转录物丰度。公共卫生相关性:这项研究与公共卫生相关,因为它将使人们更好地了解生活在人体表面和体内的微生物。由于人类本地微生物群落有助于维持健康,当受到干扰时,会导致疾病,因此这项研究可能会导致诊断或预测与微生物群落干扰相关的疾病的新测试,以及维持或恢复健康的新策略。
英文摘要
DESCRIPTION (provided by applicant): The quest to characterize the human microbiome is a daunting goal, but one that promises to enhance significantly our understanding of health and our management of a wide variety of disease states. In this quest, two features of the human microbiota in particular, pose major challenges: the large proportion and number of as-yet uncultivated species, and the extreme unevenness of the microbial communities, with a resulting large number of potentially important community members that fail to be "seen" in routine surveys. The ability to identify, isolate, and sequence the genome of single bacterial cells would allow us to characterize and understand both rare and uncultivated microbial species, and materially advance our understanding of the human microbiome. In recent work, a microfluidic device has been designed and fabricated, with features that mimic an integrated electrical circuit; this device isolates individual bacterial cells, and allows their genome to be amplified in nanoliter volumes. In this Application, a plan is proposed for optimization and augmentation of this microfluidics device, so that environmental contamination is reduced, rare cell types are more easily captured, larger numbers of cells are screened more quickly, and gene expression is more easily measured from single cells. The long-term objectives of this work are to enhance our understanding of the human microbial communities, and in particular, of novel or poorly-characterized, uncultivated microbial community members. This proposal responds to critical unmet needs posed by the NIH Human Microbiome Project. The following are the Specific Aims of this proposal: Aim 1. To reduce the contribution of environmental DNA to single cell genomic sequence data, and increase the "signal-to-noise" ratio of the sequence data obtained with our cell- sorting, genome amplification microfluidics device. The experimental approach involves the integration of optical (laser) tweezers into the device. Aim 2. To improve the ability to detect and capture rare microbial community members with the microfluidics device. The experimental approach involves the integration of fluorescence in situ hybridization techniques, specific probes, and fluorescence imaging with the microfluidics device. Aim 3. To increase the speed of single cell selection and isolation with the microfluidics device. The experimental approach involves more highly parallel microdevice designs, optimization of laser power and laser optical path, and further automation of cell manipulations. Aim 4. To enhance the capability for gene expression analysis in single bacterial cells. The experimental approach involves the development of on-chip protocols for RNA isolation, reverse transcription, and use of digital PCR to quantify transcript abundance from single cells. PUBLIC HEALTH RELEVANCE: This research is relevant to public health because it will lead to a better understanding of the microorganisms that live on and in the human body. Because the human indigenous microbial communities help to maintain health and when disturbed, contribute to disease, this research may lead to new tests for diagnosing or predicting disease associated with microbial community disturbance, and new strategies for maintaining or restoring health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Household transmission of the human gut microbiota after antibiotic exposure
-
批准号:10593834
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2022
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10624323
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10176389
-
项目类别:
-
资助金额:$72.61万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Microbial dispersal, skin-to-skin contact, and assembly of the neonatal gut microbiome
-
批准号:10178070
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10404963
-
项目类别:
-
资助金额:$72.05万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8889677
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8606066
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:9113017
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Integration of Microbe and Host Data Diagnosis of Febrile Illness
-
批准号:9241962
-
项目类别:
-
资助金额:$108.16万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8579781
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:9052450
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8878218
-
项目类别:
-
资助金额:$57.57万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8672626
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8412747
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8975217
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:8260250
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2011
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:7675064
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7940507
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7691405
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7893813
-
项目类别:
-
资助金额:$58.49万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: